Team Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-58
Closed -$1.45K 278
2025
Q4
$1.45K Buy
58
+1
+2% +$25 ﹤0.01% 250
2025
Q3
$1.46K Buy
57
+1
+2% +$25 ﹤0.01% 244
2025
Q2
$1.37K Buy
+56
New +$1.31K ﹤0.01% 239
2024
Q1
Sell
-51
Closed -$1.48K 157
2023
Q4
$1.48K Hold
51
﹤0.01% 188
2023
Q3
$1.68K Buy
+51
New +$1.8K ﹤0.01% 182

Other funds holding PFE

Team Financial Group's PFE Position: Q1 2026 in Review

Team Financial Group sold out of Pfizer (PFE) in Q1 2026, closing a stake of 58 shares — an estimated $1.45K sold.

Team Financial Group first reported a position in PFE in Q3 2023 and held it in 5 quarters. The position peaked at $1.68K in Q3 2023. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Team Financial Group reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Team Financial Group sold 58 Pfizer shares in Q1 2026, an estimated $1.45K.
  • Team Financial Group first reported a position in Pfizer in Q3 2023 and held it in 5 quarters.
  • Team Financial Group's Pfizer position peaked at $1.68K in Q3 2023.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Team Financial Group's 13F filing for Q1 2026, filed 4 May 2026.